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Background/aim: Hyperlactatemia is a common finding in critically ill patients and has significant prognostic implications. However, a
single lactate measurement has not been correlated to mortality consistently. In this study, we aimed to correlate the clinical efficacy of
lactate clearance for the prediction of mortality in pediatric intensive care unit patients.
Materials and methods: This retrospective observational study was performed in the pediatric intensive care unit in patients with
lactate level >3 mmol/lt. Initial, 6th h, and 24th h lactate levels were recorded and lactate clearance was calculated using these values
(lactate level at admission – level 6 h later × 100/lactate level at admission).
Results: A total of 172 patients were included in the study. Forty-four out of 172 patients died. Median (IQR) lactate (mmol/L) at
admission was low in those who survived in comparison to nonsurvivors 4.4 (3.1) vs. 5.75 (7.7) (p = 0.002). Clearance at 6th h was
significantly lower in those who died (11.7%) than those who survived (36.7) (p = 0.001).
6th h lactate clearance level <20.7% predicted mortality with a sensitivity of 63.6% and specificity of 69.5% along with a positive predictive
value of 41.8 and a negative predictive value of 84.8 (p = 0.004). Both lactate levels and lactate clearance values were significantly
predictive factors for mortality (p < 0.05). Only a positive moderate correlation was found between the percentage of PRISM-IV % and
6th h lactate level.
Conclusion: The present study revealed that lactate clearance is a simple and rapid risk-stratification tool holding to be a potential
biomarker of managing the treatment efficacy of children in the pediatric intensive care unit.
Key words: Hyperlactatemia, lactate clearance, intensive care unit, biomarker

1. Introduction
Hyperlactatemia is a common finding in critically ill
patients and has significant prognostic value. The severity
and duration of lactic acidosis in critically ill patients
correlate with overall oxygen debt, organ dysfunction,
and mortality. It is an indicator of inadequate oxygenation
or tissue perfusion [1–5]. However, a single lactate
measurement has not been correlated to mortality
consistently. In current studies, in addition to lactate
levels, the importance of lactate clearance (LC) is also
emphasized in terms of its relationship with mortality
[6,7]. Lactate clearance is the rate of decrease in lactate
level after resuscitation is started. This showed further
promise in predicting mortality. Various studies have
shown that persistent hyperlactatemia beyond 24–48 h
was associated with mortality, poor neurological outcome,
and organ failure [6,8,9].
A study by Nguyen et al. comparing survivors with
nonsurvivors has suggested the role of LC as a marker of

mortality prediction in adults. For every 10% increase in
LC, the probability of death decreased by approximately
11% [6]. Another study by Nazir et al. showed that 24th h
lactate clearance appears superior to 6th h lactate clearance
in predicting mortality in septic pediatric patients[7].
Therefore, we investigated clinical efficacy of lactate
clearance for the prediction of mortality in pediatric
intensive care unit patients.
2. Materials and methods
The study was conducted according to the guidelines
of the Declaration of Helsinki in 1975 as revised in
2000, and approved by the Cumhuriyet University
Ethics Committee (grant number: 2020-02/55). This
retrospective observational study was performed in
the pediatric intensive care unit of the Department of
Pediatrics between January 2015 and December 2019.
Written informed consent was obtained from all subjects
involved in the study. Patients aged from one month to 18

* Correspondence: drozlemsarac@hotmail.com

This work is licensed under a Creative Commons Attribution 4.0 International License.

1771

SARAÇ SANDAL et al. / Turk J Med Sci
years and patients with serum lactate level above 3 mmol/L
were included in the study [10–12], where patients with
metabolic disorders having elevated lactate levels and
patients deceased before 28th day of the ICU admission
period were excluded.
2.1. Methodology
Step 1
All children admitted in PICU not meeting any of the
exclusion criteria were included in the study after taking
written and informed consents.
Step 2
•
Demographic data including age, gender,
diagnosis, admission source, nature of outcome (survival/
nonsurvival), and lab parameters were recorded for each
patient into a standard medical form.
•
A standard Pediatric Risk of Mortality (PRISM)
IV, Pediatric Index of Mortality (PIM) III questionnaires,
and pediatric sequential organ failure assessment (pSOFA)
were completed for the study patients meeting with the
inclusion criteria during admission.
Step 3
•
Initial, 6th h and 24th h lactate levels were recorded
and lactate clearance was calculated using these values
(lactate level at admission–level 6 h later × 100/lactate level
at admission). A positive value determines a decrease or
clearance of lactate whereas a negative value determines
an increase in lactate.
Step 4
•
At the same time, as a subgroup patients which
were diagnosed with sepsis/septic shock (according to
the Surviving Sepsis Campaign (SSC) guidelines as the
presence of an infection with signs of organ dysfunction)
[13] were analyzed about the relationship between lactate
levels, lactate clearance, and mortality.
•
In these patients, the distinction between
infection and colonization was made according to the
prominent signs and symptoms of the patients and the
follow-up of the infection criteria [13].
2.2. Statistical analysis
The distribution of the variables was performed using
Shapiro-Wilks test. Quantitative data were presented as
mean and standard deviation where qualitative data as
median and interquartile range (IQR-25%–75%) values,
and also with numbers and percentage. The analysis of
the demographic characteristics was completed by the
chi-square test or Fisher’s exact test. The comparison of
the laboratory findings was completed by student t-test
or Mann-Whitney U test. The relation between lactate
and lactate clearance levels, and PRISM-IV, pSOFA and
PIM-III scores were conducted by Pearson’s correlation (r)
analysis. A univariate logistic regression analysis was used
to find the odds ratios of lactate and lactate clearance levels
on mortality.
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Analysis of the area under the curve (AUC) of the
receiver operating characteristic (ROC) curve was
performed to evaluate the predictive strength. Cut-off
points for initial, 6th, and 24th h lactate level and lactate
clearance were calculated by the ROC curves at the
highest sensitivity and specificity, along with the positive
predictive value, negative predictive value, and positive
and negative likelihood ratios and odds ratio for the
prediction of death.
All data were analyzed using Statistical Package
for Social Sciences (SPSS) version 20 program. The
significance level was set at p < 0.05.
3. Results
3.1. Patient characteristics
The demographic characteristics of the research population
are indicated in Table 1. A total of 172 patients were
included in the study who fulfilled inclusion criteria as
shown in Figure 1. The mean age of the study population
(n = 172) was 12 months. Of the 172 children, 89 (51.7%)
were females and 44 (26.5%) patients died. The most
frequent comorbidity was related to respiratory system,
where the intensity of emergency department admission
was the highest among others (46.5%). A 25% of the
patients was diagnosed with sepsis (Table 1).
3.2. Association between lactate kinetics, mortality
scores and outcome
Median (IQR) lactate (mmol/L) at admission was low in
those who survived in comparison to nonsurvivors 4.4 (3.1)
vs. 5.75 (7.7) (p = 0.002). A univariate logistic regression
model showed that both lactate levels and lactate clearance
values were significantly predictive factors for mortality
(Table 2).
Considering the correlation between mortality scores
and lactate levels (0, 6, 24 h) and lactate clearance levels
(6, 24 h), only a positive moderate correlation was found
between the percentage of PRISM-IV% and 6th h lactate
level (Table 3).
3.3. Serum lactate and clearances cut off of values for
predicting mortality
Using the area under receiver operating characteristic
(ROC) curve, cutoffs for mortality prediction were
determined as shown in Figure 2.
An optimal LC cut-off was defined as that LC with the
maximum sum of sensitivity plus specificity for predicting
inhospital mortality as given in Table 4.
•
Serum lactate clearance level at 6 h based on
ROC curve demonstrated a clinically acceptable sensitivity
and specificity of 63.6% and 69.5% with a cut-off value of
20.7% along with a positive predictive value of 41.8 and
a negative predictive value of 84.8 (p = 0.004) which was
associated with mortality (Table 4).
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•
Where the lactate clearance was <20.7% at 6th h,
14 out of 23 died. In those with clearance >20.7% only 30
of 149 died. ROC curve analysis for mortality prediction
was 0.67 (p < 0.004).
3.4. Subgroup analysis of septic patients
A 25% of the patients were defined as sepsis/septic shock
according to the Surviving Sepsis Campaign (SSC)
guidelines as the presence of an infection with signs of
organ dysfunction. Only three of the patient were without

septic shock. Of the total patients, 29 (64.7%) survived and
14 (32.6%) died.
At those the subsequent 6th h and 24th h lactate levels
in nonsurvivors were higher than those in survivors (p =
0.004, p = 0.014) (Table 5).
No difference was found between 6th h and 24th h lactate
clearance (p = 0.052). It was insufficient data to obtain an
acceptable ROC curve analysis and calculate an accurate
cut-off level as well in septic patients.

Table 1. The demographic characteristics of the patients.
Nonsurvivors
(n = 44)

Survivors
(n = 128)

Overall
(n = 172)

p

Age (months) Median(IQR)

12 (59)

12 (81)

12 (80)

0.635b

Gender, n (%)
Male
Female

19 (11)
25(14)

64(37)
64(37)

83(48)
89(51)

0.435a

Sepsis/septic shock

14(8.1)

29(16.9)

43(25)

Respiratory

10(5.8)

29(16.9)

39(22.7)

Cardiovascular

10(5.8)

11(6.4)

21(12.2)

Neurological

6(3.5)

31(18)

37(21.5)

Hematological

5(2.9)

18(10.5)

23(13.4)

Metabolic

6(7.6)

13(3.5)

19(11)

Intoxication

0(0)

6(3.5)

6(3.5)

ED

21(12.2)

59(34.3)

80(46.5)

Ward

13(7.6)

31(18)

44(25.6)

OT

2(1.2)

1(0.6)

3(1.7)

AH

8(4.7)

37(21.5)

45(26.2)

PRISM-IV

5(9)

14(14)

8(12)

<0.00b*

PRISM-IV (%)

2.06(7)

26.85(50)

3.29(22)

<0.001b*

pSOFA

4.5(5)

10(6)

5.5(7)

<0.001b*

PIM-III

2.4(8.1)

9.35(8.1)

3.25(13.6)

<0.001b*

Lactate initial

5.75 (7.7)

4.4(3.1)

4.7(3.7)

0.002b*

Lactate 6th h

5.8(6)

2.8(2.8)

3.25(2.67)

<0.001b*

Lactate 24th h

3.8(9.5)

1.9(1.7)

2.15(2.7)

<0.001b*

Clearence 6th h

11.7(58.51)

36.4(46.76)

32.46(48.86)

0.001

Clearence 24th h

28.38(98.97)

60.43(36.92)

57.9(49.17)

0.002

Diagnosis (n, %)

NA

Admission source (n, %)

NA

PICU scores Median (IQR)

Lactat Metrics Median (IQR)

*p<0.05aChi-square test.bMann-Whitney U test.NA, not applicable; NLC, no lactate clearance; LC, lactate clearance; ED, emergency
department; OT, operating theatre; AH, another hospital; PICU, pediatric intensive care unit; PRISM, Pediatric Risk of Mortality;
pSOFA, pediatric sequential organ failure assessment; PIM, Pediatric Index of Mortality.
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Figure 1. Flow diagram.

Table 2. Association lactate and mortality.
Variables

OR (95% CI)

p

Lactate initial

1.091 (1.017–1.069)

0.014*

Lactate 6th h

1.144 (1.060–1.234)

0.001*

Lactate 24th h

1.211 (1.105–1.326)

<0.05*

Clearance 6th h

0.985 (0.976–0.994)

0.001*

Clearance 24th h

0.985 (0.977–0.992)

<0.05*

*p < 0.05
Univariate logistic regression
OR, odds ratio; CI, confidence interval.

Table 3. The correlation between lactate levels and mortality scores.
Correlation (r)

PRISM-4

PRISM-4 %

pSOFA

PIM-3

Lactate initial

0.463

0.404

0.402

0.408

Lactate 6th h

0.501

0.520*

0.474

0.387

Lactate 24th h

0.382

0.505

0.483

0.393

Clearence 6th h

–0.272

–0.334

–0.320

–0.181

Clearence 24th h

–0.136

–0.290

–0.268

–0.168

*p < 0.05
Pearson correlation analysis.
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Figure 2. ROC analysis.

Table 4. Receiver-operating characteristic curve of lactate at 0 h, 6 h, 24 h, lactate clearance 6th h, lactate clearance 24th h rate for
predicting mortality.
Cut-off

AUC

Sensitivity

Specificity

LH+

LH-

PPV

>8.1

0.655
(0.562–0.749)

40.9
(26.3–56.8)

85.9
(78.7–91.4)

2.9
(1.7–5.1)

0.7
(0.5–0.9)

50.0
80.9
(32.9–67.1) (73.3–87.1)

<0.05*

>3.2

0.723
(0.628–0.818)

79.6
(64.7–90.2)

60.2
(51.1–68.7)

2.0
(1.5–2.6)

0.3
(0.2–0.6)

40.7
89.5
(30.2–51.8) (81.1–95.1)

<0.05*

>3.5

0.714
(0.620–0.808)

54.6
(38.8–69.6)

81.3
(73.4–87.6)

2.9
(1.9–4.6)

0.6
(0.4–0.8)

50.0
83.9
(35.2–64.8) (76.2–89.9)

<0.05*

≤20.7

0.672
(0.577–0.768)

63.6
(47.8–77.6)

69.5
(60.8–77.4)

2.1
(1.5–2.9)

0.5
(0.3–0.8)

41.8
84.8
(29.8–54.5) (76.4–91.0)

0.004*

Clearence 24th h ≤28.6

0.656
(0.552–0.759)

52.3
(36.7–67.5)

80.5
(72.5–86.9)

2.7
(1.7–4.2)

0.6
(0.4–0.8)

47.9
83.1
(33.3–62.8) (75.3–89.2)

0.003*

Lactate
initial

Lactate
6th h

Lactate
24th h

Clearence 6th h

NPV

P

AUC, area under the curve; LH, likelihood ratio, PPV, positive predictive value, NPV, negative predictive value.

4. Discussion
The predictive value of baseline lactate in critically ill
patients has been confirmed in several large cohort studies.
These studies have demonstrated that serum lactate levels
hold a crucial role in risk-stratification in critically ill
patients. It is reported during the initial stage of treatment,
lactate levels seem to be more closely associated with the

outcome compared to frequently measured parameters
such as oxygen delivery and oxygen consumption
[3,4,8,14].
In a study done by Nguyen et al., serum lactate levels
at the time of ED admission were significantly associated
with mortality. Mean serum lactate level in nonsurvivors
was 8.0 ± 4.7 mmol/L, while lactate level in survivors was
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Table 5. Lactate kinetics in septic patients.
Survivors
median(IQR)

Nonsurvivors
median (IQR)

p

Lactate initial

5.4 (7.1)

8.6 (7.3)

0.053

Lactate 6th h

4.3 (4.9)

7.4 (8.6)

0.004*

Lactate 24th h

2.4 (2.5)

7.2 (14.7)

0.014*

Clearance 6th h

32.5 (45)

5.43 (49)

0.052

Clearance 24th h

57.4 (36)

-1.95 (119.3)

0.05

*Mann Whitney U test, p < 0.05

6.1 ± 4.4 mmol/L [6]. This was comparable to our study
in which mean serum lactate at 0 h in nonsurvivors was
5.75 ± 2.5 mmol/L and lactate level in survivors was
4.4 ± 2.2 mmol/L. However, unlike this study, in our
study, 6th h lactate levels, not the initial lactate level, were
correlated with the percentage of PRISM-IV % .
Also Chebl et al. revealed that initial lactate
measurement could be a useful tool to clarify critically
ill patients regardless of age, or presence of infection
[15]. However, earlier studies found controversial
findings where Koliski et al. revealed that initial lactate
concentration could not be adequate to predict the risk of
death and merely 24th h lactate level is able to estimate the
survival rate with a sensitivity of 55.6% and a specificity of
97.2% [6,16].
As seen, a single measurement of lactate is a static
variable and can only be a risk marker. Previous studies
reported that serial lactate measurements are better
prognosticators than a single lactate measurement. To
make it more clinically useful, lactate clearance was
explored during the patients’ stay in the ICU and its
relationship with mortality was examined [9,17,18].
A systematic search of the literature reveals scarce
findings on the use of lactate measurements for the
improvement of the condition of the patient that suggested
the requirement of a new tool during medical care [18–
22]. In this regard, recent studies have demonstrated
the importance of lactate clearance rather than a single
measurement [23–28]. Walker et al. conducted a study
on children with sepsis and showed that 6th h lactate
clearance with a cut-off value of 36% had a sensitivity of
88%, a specificity of 64.1%. Lactate clearance below 36%
is closely associated with mortality where survivors had
higher lactate clearance values compared to nonsurvivors
[22]. Another study has shown a cut-off level of 34.7%
with a sensitivity of 87.5% and a specificity of 96.5% in
which patients with lower lactate clearance was prone to
an increased risk of mortality [19]. The present study has
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revealed that 6th h lactate clearance level was 20.7% which
has a sensitivity of 63.6% and specificity of 69.5% along
with a positive predictive value of 41.8 and a negative
predictive value of 84.8. We observed higher mortality
where the lactate clearance was <20.7% at 6h (p < 0.004)
which is similar to the study by Nguyen et al. [6] who
observed that clearance <10% in 6th h was associated with
higher mortality (p = 0.007). In our study, the cut-off
value is higher (20.7%), probably because they studied LC
only in cases with a septic patient, while in our study we
considered all cases in pediatric intensive care patients.
When septic patients were examined as a subgroup
in our study it was found that the subsequent 6th h and
24th h lactate levels in nonsurvivors were higher than
those in survivors (p = 0.004, p = 0.014) in septic patients
comparable to the study by Nguyen et al. and Kumar et
al. [6,17]. However, generalization could not be made due
to the small number of patients. Multicenter studies are
needed in septic patients.
Besides 6th h lactate level that is moderately correlated
with all mortality risk scores, 6th h lactate clearance
which also shows a tendency to moderately correlated
with the scores in the present study. In relation, a
logistic regression model for the prediction of mortality
confirmed the previous findings as the odds ratio of 6th
h lactate level was 1.144 (CI = 1.060–1.234) and 0.985
(CI = 0.976–0.994) for 6th h lactate clearance. These
findings could be accepted as marked evidences of the 6th
h lactate clearance is a promising new tool to follow the
improvement and recovery of the pediatric patients with
pediatric intensive care unit comparable to the study by
Kumar et al. [17].
This study is one of the few reports conducted on the
importance of lactate clearance in pediatric population and
it is more likely to represent a beneficial tool in patients
with distinct etiology.
There are some limitations in the present study.
First, the initial lactate measurement was performed
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in the PICU where it could be affected by the previous
treatments in the ward before admission to PICU. Second,
data were obtained from a single centre which may limit
the generalizability of the outcomes. We have provided
stratification and cut-off values of lactate clearance which
need validation by more multicenter studies with larger
samples.
In conclusion, we found 6th h lactate clearance
in critically ill patient was associated with mortality
prediction. Lactate clearance can probably be used as
a simple and rapid risk-stratification screening tool to
predict adverse outcomes in all pediatric critical patients.
We have provided stratification and cut-off values of
lactate clearance which need validation by more studies
with larger samples.
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